Plasminogen activator inhibitor type 2: Still an enigmatic serpin but a model for gene regulation

Methods in Enzymology

Volumn 499, Issue , 2011, Pages 105-134

  Medcalf, Robert L ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Cytoprotection; Gene regulation; Innate immunity; mRNA stability; PAI 2; SERPINB2; Transcription

Indexed keywords

5,6 DICHLORO RIBOFURANOSYLBENZIMIDAZOLE; BENZIMIDAZOLE DERIVATIVE; DACTINOMYCIN; DEXAMETHASONE; LOW DENSITY LIPOPROTEIN RECEPTOR; MANNOSE RECEPTOR; MESSENGER RNA; OKADAIC ACID; OVALBUMIN; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; PROTEASOME; PROTEIN; PROTEINASE; RETINOBLASTOMA PROTEIN; SERINE PROTEINASE INHIBITOR; TETRACYCLINE; TISSUE PLASMINOGEN ACTIVATOR; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; UROKINASE;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; BRAIN; CELL DIFFERENTIATION; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELL TYPE; COMPLEX FORMATION; CYTOLOGY; DRUG INHIBITION; EPIDERMIS; EPIGENETICS; FIBRINOLYSIS; FIBROBLAST; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE TRANSFER; GENETIC TRANSCRIPTION; HUMAN; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; KERATINOCYTE; MEDIATOR; METASTASIS; MONOCYTE; NERVE CELL; NEUROPROTECTION; NONHUMAN; PLACENTA; POSTTRANSCRIPTIONAL GENE SILENCING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; RNA STABILITY; SIGNAL TRANSDUCTION; SKIN; SQUAMOUS CELL CARCINOMA; TRANSCRIPTION REGULATION; VIRAL GENE DELIVERY SYSTEM;

EID: 79959357251     PISSN: 00766879     EISSN: 15577988     Source Type: Book Series    
DOI: 10.1016/B978-0-12-386471-0.00006-7     Document Type: Chapter

References (135)

1. T.M. Antalis, and J.L. Dickinson Control of plasminogen-activator inhibitor type 2 gene expression in the differentiation of monocytic cells Eur. J. Biochem. 205 1992 203 209
2. T.M. Antalis, M.A. Clark, T. Barnes, P.R. Lehrbach, P.L. Devine, G. Schevzov, N.H. Goss, R.W. Stephens, and P. Tolstoshev Cloning and expression of a cDNA coding for a human monocyte-derived plasminogen activator inhibitor Proc. Natl. Acad. Sci. USA 85 1988 985 989 (Pubitemid 18073947)
3. T.M. Antalis, E. Costelloe, J. Muddiman, S. Ogbourne, and K. Donnan Regulation of the plasminogen activator inhibitor type-2 gene in monocytes: Localization of an upstream transcriptional silencer Blood 88 1996 3686 3697 (Pubitemid 26383090)
4. K.M. Argraves, F.D. Battey, C.D. MacCalman, K.R. McCrae, M. Gafvels, K.F. Kozarsky, D.A. Chappell, J.F. Strauss 3rd, and D.K. Strickland The very low density lipoprotein receptor mediates the cellular catabolism of lipoprotein lipase and urokinase-plasminogen activator inhibitor type I complexes J. Biol. Chem. 270 1995 26550 26557
5. T. Bakheet, B.R. Williams, and K.S. Khabar ARED 3.0: The large and diverse AU-rich transcriptome Nucleic Acids Res. 34 2006 D111 D114
6. R. Bass, A.M. Fernandez, and V. Ellis Maspin inhibits cell migration in the absence of protease inhibitory activity J. Biol. Chem. 277 2002 46845 46848 (Pubitemid 36159185)
7. D. Belin Biology and facultative secretion of plasminogen activator inhibitor-2 Thromb. Haemost. 70 1993 144 147 (Pubitemid 23225467)
8. M.L. Bellido, R. Radpour, O. Lapaire, I. De Bie, I. Hosli, J. Bitzer, A. Hmadcha, X.Y. Zhong, and W. Holzgreve MALDI-TOF mass array analysis of RASSF1A and SERPINB5 methylation patterns in human placenta and plasma Biol. Reprod. 82 2010 745 750
9. S. Black, H. Yu, J. Lee, M. Sachchithananthan, and R.L. Medcalf Physiologic concentrations of magnesium and placental apoptosis: Prevention by antioxidants Obstet. Gynecol. 98 2001 319 324 (Pubitemid 32744769)
10. S. Borstnar, I. Vrhovec, B. Svetic, and T. Cufer Prognostic value of the urokinase-type plasminogen activator, and its inhibitors and receptor in breast cancer patients Clin. Breast Cancer 3 2002 138 146
11. C. Buechler, H. Ullrich, M. Ritter, M. Porsch-Oezcueruemez, K.J. Lackner, S. Barlage, S.O. Friedrich, G.M. Kostner, and G. Schmitz Lipoprotein (a) up-regulates the expression of the plasminogen activator inhibitor 2 in human blood monocytes Blood 97 2001 981 986 (Pubitemid 32154283)
12. J. Bystrom, T.A. Wynn, J.B. Domachowske, and H.F. Rosenberg Gene microarray analysis reveals interleukin-5-dependent transcriptional targets in mouse bone marrow Blood 103 2004 868 877 (Pubitemid 38129544)
13. E. Camerer, E. Gjernes, M. Wiiger, S. Pringle, and H. Prydz Binding of factor VIIa to tissue factor on keratinocytes induces gene expression J. Biol. Chem. 275 2000 6580 6585 (Pubitemid 30129959)
14. N. Cella, A. Contreras, K. Latha, J.M. Rosen, and M. Zhang Maspin is physically associated with [beta]1 integrin regulating cell adhesion in mammary epithelial cells FASEB J. 20 2006 1510 1512
15. G. Cesarman-Maus, and K.A. Hajjar Molecular mechanisms of fibrinolysis Br. J. Haematol. 129 2005 307 321 (Pubitemid 40646889)
16. S.T. Chelbi, and D. Vaiman Genetic and epigenetic factors contribute to the onset of preeclampsia Mol. Cell. Endocrinol. 282 2008 120 129
17. S.T. Chelbi, F. Mondon, H. Jammes, C. Buffat, T.M. Mignot, J. Tost, F. Busato, I. Gut, R. Rebourcet, P. Laissue, V. Tsatsaris, and F. Goffinet Expressional and epigenetic alterations of placental serine protease inhibitors: SERPINA3 is a potential marker of preeclampsia Hypertension 49 2007 76 83 (Pubitemid 46360344)
18. C.Y. Chen, and A.B. Shyu AU-rich elements: Characterization and importance in mRNA degradation Trends Biochem. Sci. 20 1995 465 470
19. C.Y. Chen, N. Xu, and A.B. Shyu mRNA decay mediated by two distinct AU-rich elements from c-fos and granulocyte-macrophage colony-stimulating factor transcripts: Different deadenylation kinetics and uncoupling from translation Mol. Cell. Biol. 15 1995 5777 5788
20. P. Chomczynski, and N. Sacchi Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal. Biochem. 162 1987 156 159 (Pubitemid 17064313)
21. M. Costa, Y. Shen, and R.L. Medcalf Overexpression of a dominant negative CREB protein in HT-1080 cells selectively disrupts plasminogen activator inhibitor type 2 but not tissue-type plasminogen activator gene expression FEBS Lett. 482 2000 75 80
22. E. Cousin, R.L. Medcalf, G.E. Bergonzelli, and E.K. Kruithof Regulatory elements involved in constitutive and phorbol ester-inducible expression of the plasminogen activator inhibitor type 2 gene promoter Nucleic Acids Res. 19 1991 3881 3886 (Pubitemid 21912756)
23. D.R. Croucher, D.N. Saunders, G.E. Stillfried, and M. Ranson A structural basis for differential cell signalling by PAI-1 and PAI-2 in breast cancer cells Biochem. J. 408 2007 203 210 (Pubitemid 350206343)
24. A. Csutak, D.M. Silver, J. Tozser, Z. Steiber, P. Bagossi, Z. Hassan, and A. Berta Plasminogen activator inhibitor in human tears after laser refractive surgery J. Cataract Refract. Surg. 34 2008 897 901 (Pubitemid 351699261)
25. G.A. Darnell, T.M. Antalis, R.W. Johnstone, B.W. Stringer, S.M. Ogbourne, D. Harrich, and A. Suhrbier Inhibition of retinoblastoma protein degradation by interaction with the serpin plasminogen activator inhibitor 2 via a novel consensus motif Mol. Cell. Biol. 23 2003 6520 6532 (Pubitemid 37075763)
26. R.L. Davis, A.E. Shrimpton, P.D. Holohan, C. Bradshaw, D. Feiglin, G.H. Collins, P. Sonderegger, J. Kinter, L.M. Becker, F. Lacbawan, D. Krasnewich, and M. Muenke Familial dementia caused by polymerization of mutant neuroserpin Nature 401 1999 376 379 (Pubitemid 29454960)
27. A.E. Dear, and R.L. Medcalf The cellular and molecular of plasminogen activator inhibitor type-2 Fibrinolysis 9 1995 321 330 (Pubitemid 26030963)
28. A.E. Dear, Y. Shen, M. Ruegg, and R.L. Medcalf Molecular mechanisms governing tumor-necrosis-factor-mediated regulation of plasminogen-activator inhibitor type-2 gene expression Eur. J. Biochem. 241 1996 93 100 (Pubitemid 26342976)
29. A.E. Dear, M. Costa, and R.L. Medcalf Urokinase-mediated transactivation of the plasminogen activator inhibitor type 2 (PAI-2) gene promoter in HT-1080 cells utilises AP-1 binding sites and potentiates phorbol ester-mediated induction of endogenous PAI-2 mRNA FEBS Lett. 402 1997 265 272 (Pubitemid 27078271)
30. E. Derman, K. Krauter, L. Walling, C. Weinberger, M. Ray, and J.E. Darnell Jr. Transcriptional control in the production of liver-specific mRNAs Cell 23 1981 731 739 (Pubitemid 11156984)
31. J.L. Dickinson, E.J. Bates, A. Ferrante, and T.M. Antalis Plasminogen activator inhibitor type 2 inhibits tumor necrosis factor alpha-induced apoptosis. Evidence for an alternate biological function J. Biol. Chem. 270 1995 27894 27904
32. K.M. Dougherty, J.M. Pearson, A.Y. Yang, R.J. Westrick, M.S. Baker, and D. Ginsburg The plasminogen activator inhibitor-2 gene is not required for normal murine development or survival Proc. Natl. Acad. Sci. USA 96 1999 686 691 (Pubitemid 29061269)
33. C. Duggan, S. Kennedy, M.D. Kramer, C. Barnes, P. Elvin, E. McDermott, N. O'Higgins, and M.J. Duffy Plasminogen activator inhibitor type 2 in breast cancer Br. J. Cancer 76 1997 622 627 (Pubitemid 27354676)
34. W. Eberhardt, A. Doller, el-S. Akool, and J. Pfeilschifter Modulation of mRNA stability as a novel therapeutic approach Pharmacol. Ther. 114 2007 56 73 (Pubitemid 46498160)
35. A. Eberharter, and P.B. Becker Histone acetylation: A switch between repressive and permissive chromatin. Second in review series on chromatin dynamics EMBO Rep. 3 2002 224 229 (Pubitemid 34269514)
36. J. Fan, Y.Q. Zhang, P. Li, M. Hou, L. Tan, X. Wang, and Y.S. Zhu Interaction of plasminogen activator inhibitor-2 and proteasome subunit, beta type 1 Acta Biochim. Biophys. Sin. (Shanghai) 36 2004 42 46 (Pubitemid 38507346)
37. R.J. Fish, and E.K. Kruithof Evidence for serpinB2-independent protection from TNF-alpha-induced apoptosis Exp. Cell Res. 312 2006 350 361 (Pubitemid 41814843)
38. J.A. Foekens, F. Buessecker, H.A. Peters, U. Krainick, W.L. van Putten, M.P. Look, J.G. Klijn, and M.D. Kramer Plasminogen activator inhibitor-2: Prognostic relevance in 1012 patients with primary breast cancer Cancer Res. 55 1995 1423 1427
39. G. Foltz, G.Y. Ryu, J.G. Yoon, T. Nelson, J. Fahey, A. Frakes, H. Lee, L. Field, K. Zander, Z. Sibenaller, T.C. Ryken, and R. Vibhakar Genome-wide analysis of epigenetic silencing identifies BEX1 and BEX2 as candidate tumor suppressor genes in malignant glioma Cancer Res. 66 2006 6665 6674 (Pubitemid 44085623)
40. S. Gao, B.S. Nielsen, A. Krogdahl, J.A. Sorensen, J. Tagesen, S. Dabelsteen, E. Dabelsteen, and P.A. Andreasen Epigenetic alterations of the SERPINE1 gene in oral squamous cell carcinomas and normal oral mucosa Genes Chromosom. Cancer 49 2010 526 538
41. N.L. Garneau, J. Wilusz, and C.J. Wilusz The highways and byways of mRNA decay Nat. Rev. Mol. Cell Biol. 8 2007 113 126 (Pubitemid 46432531)
42. C. Genton, E.K. Kruithof, and W.D. Schleuning Phorbol ester induces the biosynthesis of glycosylated and nonglycosylated plasminogen activator inhibitor 2 in high excess over urokinase-type plasminogen activator in human U-937 lymphoma cells J. Cell Biol. 104 1987 705 712 (Pubitemid 17024726)
43. G. Gohl, T. Lehmkoster, P.A. Munzel, D. Schrenk, R. Viebahn, and K.W. Bock TCDD-inducible plasminogen activator inhibitor type 2 (PAI-2) in human hepatocytes, HepG2 and monocytic U937 cells Carcinogenesis 17 1996 443 449
44. M.E. Greenberg, and E.B. Ziff Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene Nature 311 1984 433 438 (Pubitemid 14035448)
45. F.R. Greten, M.C. Arkan, J. Bollrath, L.C. Hsu, J. Goode, C. Miething, S.I. Goktuna, M. Neuenhahn, J. Fierer, S. Paxian, N. Van Rooijen, and Y. Xu NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta Cell 130 2007 918 931 (Pubitemid 47332565)
46. T.J. Gross, and R.G. Sitrin The THP-1 cell line is a urokinase-secreting mononuclear phagocyte with a novel defect in the production of plasminogen activator inhibitor-2 J. Immunol. 144 1990 1873 1879 (Pubitemid 20094022)
47. J.W. Harbour, and D.C. Dean Rb function in cell-cycle regulation and apoptosis Nat. Cell Biol. 2 2000 E65 E67
48. S.J. Harrop, L. Jankova, M. Coles, D. Jardine, J.S. Whittaker, A.R. Gould, A. Meister, G.C. King, B.C. Mabbutt, and P.M. Curmi The crystal structure of plasminogen activator inhibitor 2 at 2.0 resolution: Implications for serpin function Structure 7 1999 43 54 (Pubitemid 29159181)
49. R. Hasina, K. Hulett, S. Bicciato, C. Di Bello, G.J. Petruzzelli, and M.W. Lingen Plasminogen activator inhibitor-2: A molecular biomarker for head and neck cancer progression Cancer Res. 63 2003 555 559 (Pubitemid 36158130)
50. J. Herz, D.E. Clouthier, and R.E. Hammer LDL receptor-related protein internalizes and degrades uPA-PAI-1 complexes and is essential for embryo implantation Cell 71 1992 411 421
51. T. Hibino, Y. Matsuda, T. Takahashi, and P.F. Goetinck Suppression of keratinocyte proliferation by plasminogen activator inhibitor-2 J. Invest. Dermatol. 112 1999 85 90 (Pubitemid 29024711)
52. G.E. Hofmann, I. Glatstein, F. Schatz, D. Heller, and L. Deligdisch Immunohistochemical localization of urokinase-type plasminogen activator and the plasminogen activator inhibitors 1 and 2 in early human implantation sites Am. J. Obstet. Gynecol. 170 1994 671 676 (Pubitemid 24089034)
53. K. Izuhara, S. Ohta, S. Kanaji, H. Shiraishi, and K. Arima Recent progress in understanding the diversity of the human ov-serpin/clade B serpin family Cell. Mol. Life Sci. 65 2008 2541 2553
54. W.G. Jang, H.S. Kim, K.G. Park, Y.B. Park, K.H. Yoon, S.W. Han, S.H. Hur, K.S. Park, and I.K. Lee Analysis of proteome and transcriptome of tumor necrosis factor alpha stimulated vascular smooth muscle cells with or without alpha lipoic acid Proteomics 4 2004 3383 3393
55. L. Jankova, S.J. Harrop, D.N. Saunders, J.L. Andrews, K.C. Bertram, A.R. Gould, M.S. Baker, and P.M. Curmi Crystal structure of the complex of plasminogen activator inhibitor 2 with a peptide mimicking the reactive center loop J. Biol. Chem. 276 2001 43374 43382
56. P.H. Jensen, L. Lorand, P. Ebbesen, and J. Gliemann Type-2 plasminogen-activator inhibitor is a substrate for trophoblast transglutaminase and factor XIIIa. Transglutaminase-catalyzed cross-linking to cellular and extracellular structures Eur. J. Biochem. 214 1993 141 146 (Pubitemid 23168528)
57. P.H. Jensen, L.I. Cressey, B.T. Gjertsen, P. Madsen, G. Mellgren, P. Hokland, J. Gliemann, S.O. Doskeland, M. Lanotte, and O.K. Vintermyr Cleaved intracellular plasminogen activator inhibitor 2 in human myeloleukaemia cells is a marker of apoptosis Br. J. Cancer 70 1994 834 840 (Pubitemid 24331073)
58. P.H. Jensen, E. Schuler, G. Woodrow, M. Richardson, N. Goss, P. Hojrup, T.E. Petersen, and L.K. Rasmussen A unique interhelical insertion in plasminogen activator inhibitor-2 contains three glutamines, Gln83, Gln84, Gln86, essential for transglutaminase-mediated cross-linking J. Biol. Chem. 269 1994 15394 15398
59. P.H. Jensen, T.G. Jensen, W.E. Laug, H. Hager, J. Gliemann, and B. Pepinsky The exon 3 encoded sequence of the intracellular serine proteinase inhibitor plasminogen activator inhibitor 2 is a protein binding domain J. Biol. Chem. 271 1996 26892 26899 (Pubitemid 26359102)
60. D. Kaiserman, J.C. Whisstock, and P.I. Bird Mechanisms of serpin dysfunction in disease Expert Rev. Mol. Med. 8 2006 1 19 (Pubitemid 44896733)
61. L. Kardesler, N. Buduneli, B. Biyikoglu, S. Cetinkalp, and N. Kutukculer Gingival crevicular fluid PGE2, IL-1beta, t-PA, PAI-2 levels in type 2 diabetes and relationship with periodontal disease Clin. Biochem. 41 2008 863 868
62. J. Katsikis, H. Yu, F. Maurer, and R. Medcalf The molecular basis for the aberrant production of plasminogen activator inhibitor type 2 in THP-1 monocytes Thromb. Haemost. 84 2000 468 473
63. T. Kawano, K. Morimoto, and Y. Uemura Partial purification and properties of urokinase inhibitor from human placenta J. Biochem. (Tokyo) 67 1970 333 342
64. K.S. Khabar The AU-rich transcriptome: More than interferons and cytokines, and its role in disease J. Interferon Cytokine Res. 25 2005 1 10 (Pubitemid 40105586)
65. E.K. Kruithof, and E. Cousin Plasminogen activator inhibitor 2. Isolation and characterization of the promoter region of the gene Biochem. Biophys. Res. Commun. 156 1988 383 388
66. E.K. Kruithof, J.D. Vassalli, W.D. Schleuning, R.J. Mattaliano, and F. Bachmann Purification and characterization of a plasminogen activator inhibitor from the histiocytic lymphoma cell line U-937 J. Biol. Chem. 261 1986 11207 11213 (Pubitemid 17216724)
67. E.K. Kruithof, C. Tran-Thang, A. Gudinchet, J. Hauert, G. Nicoloso, C. Genton, H. Welti, and F. Bachmann Fibrinolysis in pregnancy: A study of plasminogen activator inhibitors Blood 69 1987 460 466 (Pubitemid 17022014)
68. E.K. Kruithof, M.S. Baker, and C.L. Bunn Biological and clinical aspects of plasminogen activator inhibitor type 2 Blood 86 1995 4007 4024
69. S. Kumar, and C. Baglioni Protection from tumor necrosis factor-mediated cytolysis by overexpression of plasminogen activator inhibitor type-2 J. Biol. Chem. 266 1991 20960 20964 (Pubitemid 21908558)
70. C.A. Lagnado, C.Y. Brown, and G.J. Goodall AUUUA is not sufficient to promote poly(A) shortening and degradation of an mRNA: The functional sequence within AU-rich elements may be UUAUUUA(U/A)(U/A) Mol. Cell. Biol. 14 1994 7984 7995 (Pubitemid 24373547)
71. W.E. Laug, X.R. Cao, Y.B. Yu, H. Shimada, and E.K. Kruithof Inhibition of invasion of HT1080 sarcoma cells expressing recombinant plasminogen activator inhibitor 2 Cancer Res. 53 1993 6051 6057 (Pubitemid 24006182)
72. J.A. Lee, D.R. Croucher, and M. Ranson Differential endocytosis of tissue plasminogen activator by serpins PAI-1 and PAI-2 on human peripheral blood monocytes Thromb. Haemost. 104 2010 1133 1142
73. H.R. Lijnen, L. Frederix, and I. Scroyen Deficiency of plasminogen activator inhibitor-2 impairs nutritionally induced murine adipose tissue development J. Thromb. Haemost. 5 2007 2259 2265 (Pubitemid 47617879)
74. B. Lyons-Giordano, D. Loskutoff, C.S. Chen, G. Lazarus, M. Keeton, and P.J. Jensen Expression of plasminogen activator inhibitor type 2 in normal and psoriatic epidermis Histochemistry 101 1994 105 112 (Pubitemid 24110023)
75. L. Major, W.A. Schroder, J. Gardner, R.J. Fish, and A. Suhrbier Human papilloma virus transformed CaSki cells constitutively express high levels of functional SerpinB2 Exp. Cell. Res. 317 2011 338 347
76. T. Masos, and R. Miskin mRNAs encoding urokinase-type plasminogen activator and plasminogen activator inhibitor-1 are elevated in the mouse brain following kainate-mediated excitation Brain Res. Mol. Brain Res. 47 1997 157 169 (Pubitemid 27268271)
77. A.C. Matias, P.C. Ramos, and R.J. Dohmen Chaperone-assisted assembly of the proteasome core particle Biochem. Soc. Trans. 38 2010 29 33
78. F. Maurer, and R.L. Medcalf Plasminogen activator inhibitor type 2 gene induction by tumor necrosis factor and phorbol ester involves transcriptional and post-transcriptional events. Identification of a functional nonameric AU-rich motif in the 3′-untranslated region J. Biol. Chem. 271 1996 26074 26080 (Pubitemid 26347448)
79. F. Maurer, M. Tierney, and R.L. Medcalf An AU-rich sequence in the 3′-UTR of plasminogen activator inhibitor type 2 (PAI-2) mRNA promotes PAI-2 mRNA decay and provides a binding site for nuclear HuR Nucleic Acids Res. 27 1999 1664 1673 (Pubitemid 29209542)
80. R.L. Medcalf Cell- and gene-specific interactions between signal transduction pathways revealed by okadaic acid. Studies on the plasminogen activating system J. Biol. Chem. 267 1992 12220 12226
81. R.L. Medcalf Fibrinolysis, inflammation, and regulation of the plasminogen activating system J. Thromb. Haemost. 5 Suppl 1 2007 132 142 (Pubitemid 46958826)
82. R.L. Medcalf, and S.J. Stasinopoulos The undecided serpin. The ins and outs of plasminogen activator inhibitor type 2 FEBS J. 272 2005 4858 4867 (Pubitemid 41415110)
83. R.L. Medcalf, E.K. Kruithof, and W.D. Schleuning Plasminogen activator inhibitor 1 and 2 are tumor necrosis factor/cachectin-responsive genes J. Exp. Med. 168 1988 751 759
84. P. Mikus, and T. Ny Intracellular polymerization of the serpin plasminogen activator inhibitor type 2 J. Biol. Chem. 271 1996 10048 10053 (Pubitemid 26131562)
85. P. Mikus, T. Urano, P. Liljestrom, and T. Ny Plasminogen-activator inhibitor type 2 (PAI-2) is a spontaneously polymerising SERPIN. Biochemical characterisation of the recombinant intracellular and extracellular forms Eur. J. Biochem. 218 1993 1071 1082 (Pubitemid 24010077)
86. B.M. Mueller, Y.B. Yu, and W.E. Laug Overexpression of plasminogen activator inhibitor 2 in human melanoma cells inhibits spontaneous metastasis in scid/scid mice Proc. Natl. Acad. Sci. USA 92 1995 205 209
87. M. Narita, G. Bu, J. Herz, and A.L. Schwartz Two receptor systems are involved in the plasma clearance of tissue-type plasminogen activator (t-PA) in vivo J. Clin. Invest. 96 1995 1164 1168
88. G. Nguyen, S.J. Self, C. Camani, and E.K. Kruithof Demonstration of a specific clearance receptor for tissue-type plasminogen activator on rat Novikoff hepatoma cells J. Biol. Chem. 267 1992 6249 6256
89. K. Niiya, T. Taniguchi, M. Shinbo, T. Ishikawa, S. Tazawa, Y. Hayakawa, and N. Sakuragawa Different regulation of plasminogen activator inhibitor 2 gene expression by phorbol ester and cAMP in human myeloid leukemia cell line PL-21 Thromb. Haemost. 72 1994 92 97 (Pubitemid 24202302)
90. S. Ogasawara, C. Maesawa, M. Yamamoto, Y. Akiyama, K. Wada, K. Fujisawa, T. Higuchi, Y. Tomisawa, N. Sato, S. Endo, K. Saito, and T. Masuda Disruption of cell-type-specific methylation at the Maspin gene promoter is frequently involved in undifferentiated thyroid cancers Oncogene 23 2004 1117 1124 (Pubitemid 38269965)
91. S.M. Ogbourne, and T.M. Antalis Characterisation of PAUSE-1, a powerful silencer in the human plasminogen activator inhibitor type 2 gene promoter Nucleic Acids Res. 29 2001 3919 3927 (Pubitemid 32962681)
92. V. Oji, M.E. Oji, N. Adamini, T. Walker, K. Aufenvenne, M. Raghunath, and H. Traupe Plasminogen activator inhibitor-2 is expressed in different types of congenital ichthyosis: In vivo evidence for its cross-linking into the cornified cell envelope by transglutaminase-1 Br. J. Dermatol. 154 2006 860 867
93. A. Olofsson, L. Matsson, and B. Kinnby Plasminogen activating capacity in gingival fluid from deteriorating and stable periodontal pockets J. Periodontal Res. 37 2002 60 65
94. K. Orth, E.L. Madison, M.J. Gething, J.F. Sambrook, and J. Herz Complexes of tissue-type plasminogen activator and its serpin inhibitor plasminogen-activator inhibitor type 1 are internalized by means of the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor Proc. Natl. Acad. Sci. USA 89 1992 7422 7426
95. M. Otter, M.M. Barrett-Bergshoeff, and D.C. Rijken Binding of tissue-type plasminogen activator by the mannose receptor J. Biol. Chem. 266 1991 13931 13935 (Pubitemid 21907442)
96. J.M. Park, F.R. Greten, A. Wong, R.J. Westrick, J.S. Arthur, K. Otsu, A. Hoffmann, M. Montminy, and M. Karin Signaling pathways and genes that inhibit pathogen-induced macrophage apoptosisCREB and NF-kappaB as key regulators Immunity 23 2005 319 329 (Pubitemid 41319727)
97. P.A. Pemberton, D.T. Wong, H.L. Gibson, M.C. Kiefer, P.A. Fitzpatrick, R. Sager, and P.J. Barr The tumor suppressor maspin does not undergo the stressed to relaxed transition or inhibit trypsin-like serine proteases. Evidence that maspin is not a protease inhibitory serpin J. Biol. Chem. 270 1995 15832 15837
98. B.A. Pytel, K. Peppel, and C. Baglioni Plasminogen activator inhibitor type-2 is a major protein induced in human fibroblasts and SK-MEL-109 melanoma cells by tumor necrosis factor J. Cell. Physiol. 144 1990 416 422
99. L. Qin, and M. Zhang Maspin regulates endothelial cell adhesion and migration through an integrin signaling pathway J. Biol. Chem. 285 2010 32360 32369
100. K.P. Radtke, K.H. Wenz, and N. Heimburger Isolation of plasminogen activator inhibitor-2 (PAI-2) from human placenta. Evidence for vitronectin/PAI-2 complexes in human placenta extract Biol. Chem. Hoppe Seyler 371 1990 1119 1127
101. A. Reith, N.A. Booth, N.R. Moore, D.J. Cruickshank, and B. Bennett Plasminogen activator inhibitors (PAI-1 and PAI-2) in normal pregnancies, pre-eclampsia and hydatidiform mole Br. J. Obstet. Gynaecol. 100 1993 370 374 (Pubitemid 23121160)
102. H. Ritchie, L.C. Lawrie, P.W. Crombie, M.W. Mosesson, and N.A. Booth Cross-linking of plasminogen activator inhibitor 2 and alpha 2-antiplasmin to fibrin(ogen) J. Biol. Chem. 275 2000 24915 24920 (Pubitemid 30626598)
103. E.M. Roes, C.G. Sweep, C.M. Thomas, P.L. Zusterzeel, A. Geurts-Moespot, W.H. Peters, and E.A. Steegers Levels of plasminogen activators and their inhibitors in maternal and umbilical cord plasma in severe preeclampsia Am. J. Obstet. Gynecol. 187 2002 1019 1025 (Pubitemid 35178405)
104. A. Scherrer, E.K. Kruithof, and J.P. Grob Plasminogen activator inhibitor-2 in patients with monocytic leukemia Leukemia 5 1991 479 486
105. W.D. Schleuning, R.L. Medcalf, C. Hession, R. Rothenbuhler, A. Shaw, and E.K. Kruithof Plasminogen activator inhibitor 2: Regulation of gene transcription during phorbol ester-mediated differentiation of U-937 human histiocytic lymphoma cells Mol. Cell. Biol. 7 1987 4564 4567 (Pubitemid 17166406)
106. K. Schonig, H. Bujard, and M. Gossen The power of reversibility regulating gene activities via tetracycline-controlled transcription Methods Enzymol. 477 2010 429 453
107. W.A. Schroder, T.T. Le, L. Major, S. Street, J. Gardner, E. Lambley, K. Markey, K.P. Macdonald, R.J. Fish, R. Thomas, and A. Suhrbier A physiological function of inflammation-associated SerpinB2 is regulation of adaptive immunity J. Immunol. 184 2010 2663 2670
108. W.A. Schroder, T.T. Le, L. Major, S. Street, J. Gardner, E. Lambley, K. Markey, K.P. MacDonald, R.J. Fish, R. Thomas, and A. Suhrbier A physiological function of inflammation-associated SerpinB2 is regulation of adaptive immunity J. Immunol. 184 2010 2663 2670
109. H. Sekine, J. Mimura, M. Oshima, H. Okawa, J. Kanno, K. Igarashi, F.J. Gonzalez, T. Ikuta, K. Kawajiri, and Y. Fujii-Kuriyama Hypersensitivity of aryl hydrocarbon receptor-deficient mice to lipopolysaccharide-induced septic shock Mol. Cell. Biol. 29 2009 6391 6400
110. R. Sharon, R. Abramovitz, and R. Miskin Plasminogen mRNA induction in the mouse brain after kainate excitation: Codistribution with plasminogen activator inhibitor-2 (PAI-2) mRNA Brain Res. Mol. Brain Res. 104 2002 170 175
111. M. Shiiba, H. Nomura, K. Shinozuka, K. Saito, Y. Kouzu, A. Kasamatsu, Y. Sakamoto, A. Murano, K. Ono, K. Ogawara, K. Uzawa, and H. Tanzawa Down-regulated expression of SERPIN genes located on chromosome 18q21 in oral squamous cell carcinomas Oncol. Rep. 24 2010 241 249
112. G.A. Silverman, P.I. Bird, R.W. Carrell, F.C. Church, P.B. Coughlin, P.G. Gettins, J.A. Irving, D.A. Lomas, C.J. Luke, R.W. Moyer, P.A. Pemberton, and E. Remold-O'Donnell The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature J. Biol. Chem. 276 2001 33293 33296
113. G.A. Silverman, J.C. Whisstock, D.J. Askew, S.C. Pak, C.J. Luke, S. Cataltepe, J.A. Irving, and P.I. Bird Human clade B serpins (ov-serpins) belong to a cohort of evolutionarily dispersed intracellular proteinase inhibitor clades that protect cells from promiscuous proteolysis Cell. Mol. Life Sci. 61 2004 301 325 (Pubitemid 38228416)
114. S.T. Smale Nuclear run-on assay Cold Spring Harb. Protoc. 2009 doi:10.1101/pdb.prot5329
115. S. Stasinopoulos, M. Mariasegaram, C. Gafforini, Y. Nagamine, and R.L. Medcalf The plasminogen activator inhibitor 2 transcript is destabilized via a multi-component 3′ UTR localized adenylate and uridylate-rich instability element in an analogous manner to cytokines and oncogenes FEBS J. 277 2010 1331 1344
116. E. Stratikos, and P.G. Gettins Formation of the covalent serpin-proteinase complex involves translocation of the proteinase by more than 70 A and full insertion of the reactive center loop into beta-sheet A Proc. Natl. Acad. Sci. USA 96 1999 4808 4813 (Pubitemid 29214493)
117. T.R. Sutter, K. Guzman, K.M. Dold, and W.F. Greenlee Targets for dioxin: Genes for plasminogen activator inhibitor-2 and interleukin-1 beta Science 254 1991 415 418 (Pubitemid 21917355)
118. T. Suzuki, S. Hashimoto, N. Toyoda, S. Nagai, N. Yamazaki, H.Y. Dong, J. Sakai, T. Yamashita, T. Nukiwa, and K. Matsushima Comprehensive gene expression profile of LPS-stimulated human monocytes by SAGE Blood 96 2000 2584 2591
119. M.J. Tierney, and R.L. Medcalf Plasminogen activator inhibitor type 2 contains mRNA instability elements within exon 4 of the coding region. Sequence homology to coding region instability determinants in other mRNAs J. Biol. Chem. 276 2001 13675 13684
120. O.J. Virtanen, V. Siren, J. Multanen, M. Farkkila, I. Leivo, A. Vaheri, and M. Koskiniemi Plasminogen activators and their inhibitors in human saliva and salivary gland tissue Eur. J. Oral Sci. 114 2006 22 26 (Pubitemid 43427116)
121. A.C. Webb, K.L. Collins, S.E. Snyder, S.J. Alexander, L.J. Rosenwasser, R.L. Eddy, T.B. Shows, and P.E. Auron Human monocyte Arg-Serpin cDNA. Sequence, chromosomal assignment, and homology to plasminogen activator-inhibitor J. Exp. Med. 166 1987 77 94 (Pubitemid 17101891)
122. M. Wilczynska, S. Lobov, and T. Ny The spontaneous polymerization of plasminogen activator inhibitor type-2 and Z-antitrypsin are due to different molecular aberrations FEBS Lett. 537 2003 11 16 (Pubitemid 36246668)
123. L.R. Wing, G.M. Hawksworth, B. Bennett, and N.A. Booth Clearance of t-PA, PAI-1, and t-PA-PAI-1 complex in an isolated perfused rat liver system J. Lab. Clin. Med. 117 1991 109 114
124. R. Winzen, G. Gowrishankar, F. Bollig, N. Redich, K. Resch, and H. Holtmann Distinct domains of AU-rich elements exert different functions in mRNA destabilization and stabilization by p38 mitogen-activated protein kinase or HuR Mol. Cell. Biol. 24 2004 4835 4847 (Pubitemid 38668049)
125. R. Winzen, B.K. Thakur, O. Dittrich-Breiholz, M. Shah, N. Redich, S. Dhamija, M. Kracht, and H. Holtmann Functional analysis of KSRP interaction with the AU-rich element of interleukin-8 and identification of inflammatory mRNA targets Mol. Cell. Biol. 27 2007 8388 8400 (Pubitemid 350234249)
126. A. Wohlwend, D. Belin, and J.D. Vassalli Plasminogen activator-specific inhibitors in mouse macrophages: In vivo and in vitro modulation of their synthesis and secretion J. Immunol. 139 1987 1278 1284 (Pubitemid 17134188)
127. T.C. Wun, and E. Reich An inhibitor of plasminogen activation from human placenta. Purification and characterization J. Biol. Chem. 262 1987 3646 3653 (Pubitemid 17132926)
128. R.D. Ye, T.C. Wun, and J.E. Sadler Mammalian protein secretion without signal peptide removal. Biosynthesis of plasminogen activator inhibitor-2 in U-937 cells J. Biol. Chem. 263 1988 4869 4875
129. R.D. Ye, S.M. Ahern, M.M. Le Beau, R.V. Lebo, and J.E. Sadler Structure of the gene for human plasminogen activator inhibitor-2. The nearest mammalian homologue of chicken ovalbumin J. Biol. Chem. 264 1989 5495 5502 (Pubitemid 19098003)
130. H. Yoshino, Y. Endo, Y. Watanabe, and T. Sasaki Significance of plasminogen activator inhibitor 2 as a prognostic marker in primary lung cancer: Association of decreased plasminogen activator inhibitor 2 with lymph node metastasis Br. J. Cancer 78 1998 833 839 (Pubitemid 28418323)
131. H. Yu, F. Maurer, and R.L. Medcalf Plasminogen activator inhibitor type 2: A regulator of monocyte proliferation and differentiation Blood 99 2002 2810 2818 (Pubitemid 34525369)
132. H. Yu, S. Stasinopoulos, P. Leedman, and R.L. Medcalf Inherent instability of plasminogen activator inhibitor type 2 mRNA is regulated by tristetraprolin J. Biol. Chem. 278 2003 13912 13918 (Pubitemid 36799932)
133. M. Zhang, N. Maass, D. Magit, and R. Sager Transactivation through Ets and Ap1 transcription sites determines the expression of the tumor-suppressing gene maspin Cell Growth Differ. 8 1997 179 186 (Pubitemid 27068895)
134. S.J. Zhang, M. Zou, L. Lu, D. Lau, D.A. Ditzel, C. Delucinge-Vivier, Y. Aso, P. Descombes, and H. Bading Nuclear calcium signaling controls expression of a large gene pool: Identification of a gene program for acquired neuroprotection induced by synaptic activity PLoS Genet. 5 2009 e1000604
135. H.M. Zhou, I. Bolon, A. Nichols, A. Wohlwend, and J.D. Vassalli Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice Cancer Res. 61 2001 970 976 (Pubitemid 32174413)